|
You
are here: Home: BCU 6|2003: Faculty
Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of NL
Communications Inc to require the disclosure of any significant
financial interest or any other relationship the sponsor or faculty
members have with the manufacturer(s) of any commercial product(s)
discussed in an educational presentation. The presenting faculty
reported the following:
|
Monica Morrow,
MD
|
No financial interests or affiliations to disclose |
Joyce O’Shaughnessy,
MD
|
Consultant: Eli Lilly & Company,
Roche Laboratories Inc, Aventis Pharmaceuticals Inc, Ortho
Biotech Products LP
Speakers’ Bureau: Roche Laboratories
Inc, Aventis Pharmaceuticals, Eli Lilly & Company, Ortho
Biotech Products LP |
Kathy S Albain,
MD
|
Grants/Research Support/Speakers’ Bureau: AstraZeneca
Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Eli Lilly & Company,
Bristol-Myers Squibb, Genentech Inc |
Robert W Carlson,
MD
|
Grants/Research Support: Eli
Lilly & Company, Aventis Pharmaceuticals Inc, AstraZeneca
Pharmaceuticals LP
Honorarium: AstraZeneca Pharmaceuticals LP |
This educational activity contains discussion of published and/or
investigational uses of agents that are not indicated by the FDA.
NL Communications Inc does not recommend the use of any agent outside
of the labeled indications. Please refer to the official prescribing
information for each product for discussion of approved indications,
contraindications and warnings. The opinions expressed are those
of the presenters and are not to be construed as those of the publisher
or grantor.
|
|